Duration of botulinum toxin effect in the treatment of crocodile tears

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 6, 2006, Pages 453-456

  Nava Castañeda, Angel ^a,b   Tovilla Canales, Jose L ^a   Boullosa, Victor ^a   Tovilla y Pomar, Jose L ^a   Monroy Serrano, Maria H ^a   Tapia Guerra, Victor ^a   Garfias, Yonathan ^a  

^a INSTITUTE OF OPHTHALMOLOGY CONDE DE VALENCIANA   (Mexico)

^b NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; PONTI OFTENO; TETRACAINE; TOBRAMYCIN; TRAZIL OFTENO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CROCODILE TEARS SYNDROME; DRUG EFFECT; EPIPHORA; FEMALE; HUMAN; LACRIMAL GLAND; LACRIMATION DISORDER; MALE; PRIORITY JOURNAL; PTOSIS; QUESTIONNAIRE; SCHIRMER TEST; SLIT LAMP; TREATMENT DURATION; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; LACRIMAL APPARATUS; LACRIMAL APPARATUS DISEASES; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PATIENT SATISFACTION; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33751225651     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000244515.07925.99     Document Type: Article

References (12)

1. Keegan DJ, Geerling G, Lee JP, et al. Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation. Br J Ophthalmol 2002;86:43-6.
2. Rienmann R, Pfennigsdorf S, Riemann E, et al. Successful treatment of crocodile tears by injection of botulinum toxin into the lacrimal gland. Ophthalmology 1999;106:2322-4.
3. Montoya FJ, Riddell CE, Caesar R, et al. Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland. Eye 2002;16:705-9.
4. McCoy FJ, Goodman RC. The crocodile tear syndrome. Plast Reconstr Surg 1979;63:58-60.
5. Kyrmizkis KE, Pangalos A, Papakakis C, et al. The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes. J Oral Maxillofac Surg 2004;62:840-4.
6. Reha Y, Yavuz B, Fikret A. Botulinum toxin A for the treatment of crocodile tears. Plast Reconstr Surg 2002;110:369-70.
7. Boroojerdi B, Ferbert A, Schwarz M. Botulinum toxin treatment of synkinesia and hyperlacrimation after facial palsy. J Neurol Neurosurg Psychiatry 1998;65:111-4.
8. Hofmann R. Treatment of Frey's syndrome (gustatory sweating) and "crocodile tears" (gustatory epiphora) with purified botulinum toxin. Ophthal Plast Reconstr Surg 2000;16:289-91.
9. Nauman M, Jost W, Toyka K. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch Neurol 1999;56:914-6.
10. Baranano DE, Miller NR. Long-term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome. Br J Ophthalmol 2004;88:588-9.
11. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol 1991;36:28-46.
12. Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol 1988;106:570-4.